Novel strategies, such as the transfection of tumor migratory chemokines and their receptors, CXCL11 [57] and CCR2 [58], have been utilized to enhance the tumor localization of CAR-T cells with significant success. The gene discussed is CXCL11; the disease is neoplasm.